Related Experiment Video
Updated: Jun 4, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
Induction of phenotype modifying cytokines by FERMT1 mutations
Anja Heinemann1, Yinghong He, Elena Zimina
1Department of Dermatology, University of Freiburg, Freiburg, Germany.
Abstract:
Kindler syndrome (KS) is a progressive skin disorder caused by FERMT1 mutations. Early in life, KS manifests as a mechanobullous disease reflecting diminished cell adhesion, but the mechanisms of its later phenotypic features, progressive poikiloderma, and mucocutaneous fibrosis, remain elusive. The FERMT1 gene product and KS protein, kindlin-1, is an epithelial-specific phosphoprotein involved in integrin beta-1 activation, without an obvious link to dermal connective tissue. Here we show how lack of intracellular kindlin-1 in epidermal keratinocytes leads to profound changes in another skin compartment, the dermis. Kindlin-1-deficient keratinocytes respond to cell stress by upregulating the expression of cytokines such as IL-20, IL-24, TGF-β2, IL1F5, PDGFB, and CTGF. These launch-via paracrine communication-an inflammatory response in the dermis, accompanied by the presence of TGF-β, IL-6, and CTGF, activation of fibroblasts and their differentiation to myofibroblasts, which secrete and deposit increased amounts of extracellular matrix proteins. These data are concordant with a model wherein repeated cycles of epidermal cell stress, cytokine secretion, dermal inflammation, and profibrotic processes underlie mucocutaneous fibrosis in KS.
Insights
Kindler syndrome, a skin disorder from FERMT1 mutations, involves epidermal stress triggering dermal inflammation and fibrosis. This study reveals how keratinocyte defects in kindlin-1 drive progressive skin damage.
Area of Science:
- Dermatology
- Molecular Biology
- Genetics
Background:
- Kindler syndrome (KS) is a rare, progressive skin disorder caused by mutations in the FERMT1 gene, leading to diminished cell adhesion and early mechanobullous disease.
- The underlying mechanisms for later KS features, including poikiloderma and mucocutaneous fibrosis, are not fully understood.
- Kindlin-1, the FERMT1 gene product, is crucial for integrin activation in epithelial cells, but its role in dermal connective tissue pathology was unclear.
Purpose of the Study:
- To elucidate the mechanisms by which loss of intracellular kindlin-1 in epidermal keratinocytes contributes to the dermal pathology observed in Kindler syndrome.
- To investigate the paracrine signaling pathways initiated by stressed, kindlin-1-deficient keratinocytes that affect dermal fibroblasts.
Main Methods:
- Analysis of kindlin-1-deficient keratinocytes and their response to cellular stress.
- Assessment of cytokine expression profiles in stressed keratinocytes.
- Investigation of downstream effects in the dermis, including inflammatory cell presence, fibroblast activation, and extracellular matrix deposition.
Main Results:
- Kindlin-1-deficient keratinocytes exhibit upregulated expression of pro-inflammatory and profibrotic cytokines (e.g., IL-20, IL-24, TGF-β2, PDGFB, CTGF) upon cellular stress.
- These secreted cytokines induce a paracrine inflammatory response in the dermis, characterized by the presence of TGF-β, IL-6, and CTGF.
- The dermal inflammatory milieu promotes fibroblast activation and differentiation into myofibroblasts, leading to excessive extracellular matrix deposition.
Conclusions:
- Epidermal kindlin-1 deficiency initiates a cascade involving keratinocyte stress, cytokine signaling, dermal inflammation, and fibroblast activation.
- This pathway provides a mechanistic link between epithelial defects and the development of progressive dermal fibrosis in Kindler syndrome.
- Targeting these paracrine signaling pathways may offer therapeutic strategies for managing the fibrotic complications of Kindler syndrome.
Related Concept Videos
TGF - β Signaling Pathway
Forced Transdifferentiation
Artificial transdifferentiation occurs...
Abnormal Proliferation